鈴木, 恵三 高梨, 勝男 名出, 頼男 藤田, 民夫 小川, 忠 平林, 聰 玉井, 秀亀 柳岡, 正範 石黒, 幸一 浅野, 晴好
...
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who...
鈴木, 恵三 高梨, 勝男 名出, 頼男 藤田, 民夫 小川, 忠 平林, 聰 玉井, 秀亀 柳岡, 正範 石黒, 幸一 浅野, 晴好
...
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who...
鈴木, 恵三 高梨, 勝男 名出, 頼男 藤田, 民夫 小川, 忠 平林, 聰 玉井, 秀亀 柳岡, 正範 石黒, 幸一 浅野, 晴好
...
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who...
鈴木, 恵三 高梨, 勝男 名出, 頼男 藤田, 民夫 小川, 忠 平林, 聰 玉井, 秀亀 柳岡, 正範 石黒, 幸一 浅野, 晴好
...
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who...
鈴木, 恵三 高梨, 勝男 名出, 頼男 藤田, 民夫 小川, 忠 平林, 聰 玉井, 秀亀 柳岡, 正範 石黒, 幸一 浅野, 晴好
...
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who...
Majtánová, L'. Majtán, V.
Published in
Folia Microbiologica
The influence of the postantibiotic effect (PAE) and the postantibiotic sub-MICs effect (PA SME) of imipenem and enoxacin on the surface hydrophobicity ofS. typhimurium andS. enteritidis strains were studied by evaluating Congo red binding and the aggregation in molar solutions of ammonium sulfate (SAT). A PAE was induced by 2× and 4× MIC of antibi...
Hupková, H. Trupl, J.
Published in
Folia Microbiologica
In vitro susceptibility of eight antibiotics was compared using three groups of pneumococci and agar dilution method comprising 30 penicillin-susceptible, 30 intermediately penicillin-resistant, and 30 highly penicillin-resistant pneumococci. Decreased sensitivity to all β-lactam agents of intermediately penicillin-resistant and highly penicillin-r...
Garbino, J. Villiger, P. Caviezel, A. Matulionyte, R. Uckay, I. Morel, P. Lew, D.
Published in
Infection
Background:Presumptive antimicrobial therapy is an important aspect of the management of intra-abdominal infections. Together with surgery, antimicrobial combinations are still widely used to achieve the required spectrum of activity. The aim of this study was to evaluate the efficacy of parenteral cefepime + metronidazole vs imipenemcilastatin for...
Kresken, M. Hafner, D.
Published in
Infection
A multicenter study for monitoring antimicrobial drug resistance in clinical isolates of the familyEnterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus andEnterococcus species in central Europa conducted by the Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy has been ongoing since 1975. Between 1975 and 1995 susc...
Hoštacká, A.
Published in
Folia Microbiologica
Six strains ofAcinetobacter baumannii out of eleven strains tested revealed a strong hydrophobic character. This was demonstrated by adherence of bacteria to xylene in the range of 90–94%. Changes in surface hydrophobicity of these strains were studied after treatment with meropenem at subinhibitory concentrations (sub-MICs) (1/4, 1/8, 1/16 or 1/32...